Glutamine–glutamate imbalance in the pathogenesis of cardiovascular disease

Abstract

Glutaminase-2 (GLS2) is crucial for glutamine metabolism and its deficiency causes increased plasma glutamine levels, disrupted extracellular matrix remodeling and accelerated plaque progression. Findings reveal a metabolic link between hepatic glutamine homeostasis and the vasculature and potential therapeutic strategies for cardiovascular disease.